Ascendis Pharma A/S
ASND NASDAQHealthcare ★★★★★Latest Earnings FY2026 Q2 Above forecast↑
Date
Aug 13, 2026
ET
EPS Est.
1.71
EPS Actual
3.29
Revenue Est.
$376.8M
Revenue Actual
$387.5M
Next Earnings Report
Date
Nov 11, 2026 · Wed
ET Nov 11, 2026 · Wed
Time
11/11 11:00-14:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
1.13
Revenue Est.
$473.5M
Company Overview
Ascendis Pharma A/S (ticker ASND) is listed on NASDAQ with a market cap of about $14.15B. Its next earnings report (FY2026 Q3) is expected on Nov 11, 2026 (ET), Pre-market, with consensus EPS of 1.13. In the last 15 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently15Term · Feb 16, 2023 → FY2026 Q2
Feb 16, 2023Range: -3.96 ~ 3.29FY2026 Q2
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 13, 2026 | FY2026 Q2 | 1.71 | Above forecast↑3.29 | $376.8M | $387.5M |
| May 7, 2026 | -- | 0.19 | Above forecast↑0.32 | $308.9M | $284.9M |
| Feb 11, 2026 | -- | -0.06 | Below forecast↓-0.64 | $292.3M | $344.8M |
| Nov 12, 2025 | -- | -0.41 | Below forecast↓-1.17 | $302.6M | $250.2M |
| Aug 7, 2025 | -- | -1.42 | Above forecast↑-0.93 | $233.1M | $186.1M |
| May 1, 2025 | -- | -1.56 | Below forecast↓-1.66 | $153.5M | $110.7M |
| Feb 12, 2025 | -- | -1.20 | Above forecast↑-0.68 | $125.4M | $180.1M |
| Nov 14, 2024 | -- | -1.83 | Above forecast↑-1.81 | $74.1M | $63.4M |
| Sep 3, 2024 | -- | -1.54 | Below forecast↓-2.05 | $37.6M | $38.7M |
| May 2, 2024 | -- | -1.62 | Below forecast↓-2.48 | $92.4M | $103M |
| Feb 7, 2024 | -- | -2.19 | Above forecast↑-1.66 | $111.1M | $151.4M |
| Nov 7, 2023 | -- | -2.55 | Below forecast↓-3.08 | $55.3M | $50.7M |
| Sep 5, 2023 | -- | -2.68 | Above forecast↑-2.35 | $43.5M | $55.4M |
| Apr 27, 2023 | -- | -2.93 | Above forecast↑-2.18 | $25.8M | $36.5M |
| Feb 16, 2023 | -- | -2.74 | Below forecast↓-3.96 | $22M | $24.7M |
Original Filings (SEC)
Earnings Release6-K · 2026-08-13 ↗
Earnings Release6-K · 2026-08-13 ↗
Earnings Release6-K · 2026-08-12 ↗
Earnings Release6-K · 2026-05-07 ↗
Earnings Release6-K · 2026-05-07 ↗
Earnings Release6-K · 2026-02-11 ↗
Annual20-F · 2026-02-11 ↗
Earnings Release6-K · 2026-02-11 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
